JP2023526853A5 - - Google Patents

Info

Publication number
JP2023526853A5
JP2023526853A5 JP2022571157A JP2022571157A JP2023526853A5 JP 2023526853 A5 JP2023526853 A5 JP 2023526853A5 JP 2022571157 A JP2022571157 A JP 2022571157A JP 2022571157 A JP2022571157 A JP 2022571157A JP 2023526853 A5 JP2023526853 A5 JP 2023526853A5
Authority
JP
Japan
Prior art keywords
pharmaceutical composition
composition according
antibody
antagonist
viral
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2022571157A
Other languages
English (en)
Japanese (ja)
Other versions
JP2023526853A (ja
Filing date
Publication date
Priority claimed from GBGB2007404.3A external-priority patent/GB202007404D0/en
Application filed filed Critical
Publication of JP2023526853A publication Critical patent/JP2023526853A/ja
Publication of JP2023526853A5 publication Critical patent/JP2023526853A5/ja
Pending legal-status Critical Current

Links

JP2022571157A 2020-05-19 2021-05-19 ウイルス性呼吸器感染症の処置 Pending JP2023526853A (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
GBGB2007404.3A GB202007404D0 (en) 2020-05-19 2020-05-19 Treatment for viral respiratory infections
GB2007404.3 2020-05-19
PCT/GB2021/051207 WO2021234381A1 (en) 2020-05-19 2021-05-19 Treatment for viral respiratory infections

Publications (2)

Publication Number Publication Date
JP2023526853A JP2023526853A (ja) 2023-06-23
JP2023526853A5 true JP2023526853A5 (cg-RX-API-DMAC7.html) 2024-02-13

Family

ID=71135334

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2022571157A Pending JP2023526853A (ja) 2020-05-19 2021-05-19 ウイルス性呼吸器感染症の処置

Country Status (12)

Country Link
US (1) US20230192838A1 (cg-RX-API-DMAC7.html)
EP (1) EP4153302B1 (cg-RX-API-DMAC7.html)
JP (1) JP2023526853A (cg-RX-API-DMAC7.html)
KR (1) KR20230053549A (cg-RX-API-DMAC7.html)
CN (1) CN116406289A (cg-RX-API-DMAC7.html)
AU (1) AU2021276614A1 (cg-RX-API-DMAC7.html)
CA (1) CA3179461A1 (cg-RX-API-DMAC7.html)
ES (1) ES2982939T3 (cg-RX-API-DMAC7.html)
GB (1) GB202007404D0 (cg-RX-API-DMAC7.html)
HU (1) HUE067327T2 (cg-RX-API-DMAC7.html)
PL (1) PL4153302T3 (cg-RX-API-DMAC7.html)
WO (1) WO2021234381A1 (cg-RX-API-DMAC7.html)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20230314432A1 (en) * 2020-07-10 2023-10-05 Covid Diagnostics Ltd. Compositions, methods, and systems for detecting immune response

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE69233528T2 (de) 1991-11-25 2006-03-16 Enzon, Inc. Verfahren zur Herstellung von multivalenten antigenbindenden Proteinen
US20040198706A1 (en) 2003-03-11 2004-10-07 Carrara Dario Norberto R. Methods and formulations for transdermal or transmucosal application of active agents
GB0300531D0 (en) 2003-01-10 2003-02-12 West Pharm Serv Drug Res Ltd Pharmaceutical compositions
AU2005327198B2 (en) 2004-07-09 2011-03-31 University Of North Carolina At Chapel Hill Viral adjuvants
EP2112923A1 (en) 2007-01-22 2009-11-04 Targacept Inc. Intranasal, buccal, and sublingual administration of metanicotine analogs
BR112013015508B1 (pt) * 2010-12-20 2022-04-05 Medimmune Limited Molécula de anticorpo para il-18 humana, domínio vh isolado e domínio vl isolado, composição, uso de uma molécula de anticorpo ou do domínio vh isolado e do domínio vl isolado, molécula de ácido nucleico isolada, célula hospedeira procariótica recombinante, método para produzir um anticorpo, e método in vitro para medir il-18 em uma amostra de um indivíduo
WO2015032932A1 (en) * 2013-09-05 2015-03-12 Ab2 Bio Sa Il-18 binding protein (il-18bp) in inflammatory diseases
CN107660150B (zh) * 2015-03-05 2023-10-24 Ab2生物股份有限公司 Il-18结合蛋白(il-18bp)和抗体在炎性疾病中
EP4146174A1 (en) * 2020-05-06 2023-03-15 AB2 Bio SA Il-18 binding protein (il-18bp) in respiratory diseases

Similar Documents

Publication Publication Date Title
JP7854016B2 (ja) 腫瘍治療薬及びその応用
JP2023515271A5 (cg-RX-API-DMAC7.html)
JP2018535650A5 (cg-RX-API-DMAC7.html)
JP2023080215A (ja) 肝細胞癌のための免疫療法
JP2008518936A5 (cg-RX-API-DMAC7.html)
RU2012141556A (ru) Способы и композиции для лечения болезни дего
JP2017507652A5 (cg-RX-API-DMAC7.html)
FI3484915T3 (fi) Uusia zikavirusepitooppeihin spesifisesti sitoutuvia vasta-aineita ja niiden käyttöjä
JP2009511480A5 (cg-RX-API-DMAC7.html)
JP2010521470A5 (cg-RX-API-DMAC7.html)
JP2019505527A5 (cg-RX-API-DMAC7.html)
JP2011501737A5 (cg-RX-API-DMAC7.html)
JP2023549067A5 (cg-RX-API-DMAC7.html)
JP2023528441A5 (cg-RX-API-DMAC7.html)
JPWO2023026791A5 (cg-RX-API-DMAC7.html)
JP2004534513A5 (cg-RX-API-DMAC7.html)
JP2024503784A5 (cg-RX-API-DMAC7.html)
CN117100853A (zh) 生物制药组合物和相关方法
JP2025514978A5 (cg-RX-API-DMAC7.html)
JP2023534922A5 (cg-RX-API-DMAC7.html)
JP2010521139A5 (cg-RX-API-DMAC7.html)
JP2023537078A5 (cg-RX-API-DMAC7.html)
JP2025087764A5 (cg-RX-API-DMAC7.html)
JP2018529328A5 (cg-RX-API-DMAC7.html)
FI4244252T3 (fi) Kroonisen obstruktiivisen keuhkosairauden hoito anti-interleukiini-33-vasta-aineella